HomeKLRS • NASDAQ
add
Kalaris Therapeutics Inc
Previous close
$2.83
Day range
$2.65 - $2.87
Year range
$2.65 - $24.15
Market cap
52.18M USD
Avg Volume
64.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.35M | 303.98% |
Net income | -10.20M | -199.27% |
Net profit margin | — | — |
Earnings per share | -2.52 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 100.96M | — |
Total assets | 103.09M | — |
Total liabilities | 39.22M | — |
Total equity | 63.87M | — |
Shares outstanding | 18.70M | — |
Price to book | 0.83 | — |
Return on assets | -47.38% | — |
Return on capital | -156.11% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -10.20M | -199.27% |
Cash from operations | -7.44M | -64.59% |
Cash from investing | — | — |
Cash from financing | 107.27M | 1,530.45% |
Net change in cash | 99.83M | 4,750.63% |
Free cash flow | -4.83M | — |
About
Founded
2019
Headquarters
Website
Employees
14
